1. COVID is killing 120 people an hour in India, and it could stay "really grim" for months  CBS News
  2. The latest on Covid-19 and India's worsening crisis: Live updates  CNN
  3. Covid-19: Why It's Hard to Vaccinate the World  The New York Times
  4. COVID-19 Latest: Wolf to lift mitigation orders; Vaccine shots will go where there's demand  Pittsburgh Post-Gazette
  5. One pharmacy, 30K vaccines  WISN 12 News
  6. View Full Coverage on Google News

www.cnn.com

President Biden said Tuesday that the US is "ready to move immediately" if federal regulators approve Pfizer's COVID-19 vaccine for children as young as 12 years old in the near future.President Joe Biden announced that the United States is prepared for when the FDA approves the Pfizer COVID-19 vaccine for children aged 12 to 15 years old.

Biden: US 'ready to move immediately' when Pfizer vax approved for teens

The Centers For Disease Control and Prevention is currently reviewing the death of a Michigan woman who received the Johnson & Johnson vaccine, though there is currently no evidence that her death and the vaccine are linked, officials said.The Centers For Disease Control and Prevention is currently reviewing the death of a Michigan woman who received the Johnson & Johnson vaccine, though there is currently no evidence that her death and the vaccine are linked, officials said.

CDC reviews death of Michigan woman who got Johnson & Johnson vaccine -- everything you should know

d1akq03u1jevln.cloudfront.net

Progress relies on learning from errors; 2020 was a year of errors and suffering, but also of important lessons we can apply to the future.Progress relies on learning from errors; 2020 was a year of errors and suffering, but also of important lessons we can apply to the future.

COVID vaccine: I predicted few people would take it. I was wrong.

downloadmedia.gannett-cdn.com

Big-power muscle flexing helps explain much of the world’s vaccine inequities, but there's another reason behind insufficient doses: The challenge of making them is unprecedented.Big-power muscle flexing helps explain much of the world’s vaccine inequities, but there's another reason behind insufficient doses: The challenge of making them is unprecedented.

www.nytimes.com

We're temporarily down for maintenance; Please check back soon...

News24 looks at how many people still have to be vaccinated in the current phase, when mass vaccinations are likely to start, and how many vaccines the country has acquired. News24 looks at how many people still have to be vaccinated in the current phase, when mass vaccinations are likely to start, and how many vaccines the country has acquired.

EXPLAINER | What is the state of SA’s vaccination drive? | News24

The federally-supported COVID-19 vaccination site at Gateway Mall will stop giving first doses of the Pfizer vaccine to those 16 and up after Tuesday.The federally-supported COVID-19 vaccination site at Gateway Mall will stop giving first doses of the Pfizer vaccine to those 16 and up after Tuesday.

Tuesday is final day for 1st dose Pfizer shots at Gateway Mall site

The company delivered huge revenue and earnings growth that beat Wall Street's expectations.The company delivered huge revenue and earnings growth that beat Wall Street's expectations.

Pfizer Knocks It Out of the Park With Its Q1 Results | The Motley Fool

The Pennsylvania Department of Health today confirmed as of 12:00 a.m., May 3, there were 1,728 additional positive cases of COVID-19, in addition to 2,653 new cases reported Sunday, May 2, for a two-day total of 4,381 additional positive cases of COVID-19.HARRISBURG, Pa. (WHTM) — The Pennsylvania Department of Health today confirmed as of 12:00 a.m., May 3, there were 1,728 additional positive cases of COVID-19, in addition to 2,653 new cases …

Coronavirus in Pennsylvania: 4,381 new 2-day cases, 1,158,486 total as of May 1, 2021

There are persistent shortages of oxygen, hospital space, medicines and - crucially - vaccines, and the virus may not have even hit rural India yet.There are persistent shortages of oxygen, hospital space, medicines and - crucially - vaccines, and the virus may not have even hit rural India yet.

news.yahoo.com

The family of an Ionia-area wife and mother says she died due to complications after receiving the J&J COVID-19 vaccine. The family of an Ionia-area wife and mother says she died due to complications after receiving the J&J COVID-19 vaccine.

CDC investigating Ionia Co. woman’s death after getting J&J vaccine | WOODTV.com

404 Not Found

HARRISBURG, Pa. (WTAJ) — The Pennsylvania Department of Health has confirmed 3,133 new cases of COVID-19 since yesterday, bringing state totals to 1,161,619 known cases since the start of the pandemic. Since Monday, 58 new death has been identified by the Pennsylvania death registry, bringing a total of 26,334 deaths attributed to COVID-19. There are 2,151 individuals […]HARRISBURG, Pa. (WTAJ) — The Pennsylvania Department of Health has confirmed 3,133 new cases of COVID-19 since yesterday, bringing state totals to 1,161,619 known cases since the start of…

3,133 new COVID cases reported, 172 in our central region May 4, 2021 | WTAJ - www.wearecentralpa.com

A daily roundup of news on COVID-19 and the rest of medicineA daily roundup of news on COVID-19 and the rest of medicine

Pfizer Vax in Young Teens? India's Trainees Join Front Line; Fla. Ends COVID Rules | MedPage Today

Bloomberg - Are you a robot?

Pfizer now expects to be able to deliver about 2.5 billion vaccine doses this year and already has signed contracts covering about 1.6 billion of those doses. The company also has begun testing a pill to treat COVID-19.Pfizer now expects to be able to deliver about 2.5 billion vaccine doses this year and already has signed contracts covering about 1.6 billion of those doses. The company also has begun testing a pill to treat COVID-19.

Pfizer, making billions from vaccine sales, blows past Wall Street expectations - Chicago Tribune

European Medicine Agency started to evaluate if application of BioNTech/Pfizer jabs can be extended to ages 12-15 - Anadolu AgencyEuropean Medicine Agency started to evaluate if application of BioNTech/Pfizer jabs can be extended to ages 12-15 - Anadolu Agency

EU drug agency reviewing BioNTech shots for ages 12-15

COVID-19 "Breakthrough Cases" come from people who test positive for COVID-19 after they are already fully vaccinated. Missouri reported just 14 of these particular cases to Federal Health Officials, even though 96 such cases have been detected in just the state's largest county. Some cases have even been found in Boone County. Officials with the Columbia and Boone County Health Department said three Boone County Residents have been hospitalized two weeks after their second COVID-19 vaccine. COVID-19 "Breakthrough Cases" come from people who test positive for COVID-19 after they are already fully vaccinated. Missouri reported just 14 of these particular cases to Federal Health Officials, even though 96 such cases have been detected in just the state's largest county. Some cases have even been found in Boone County. Officials with the Columbia and Boone County Health Department said three Boone County Residents have been hospitalized two weeks after their second COVID-19 vaccine.

Missouri sees a few COVID-19 "Breakthrough Cases" | KRCG

Missouri sees a few COVID-19 "Breakthrough Cases"

Doctors say there is no way to know for certain the cause but did not see any evidence of a blood clot.Doctors say there is no way to know for certain the cause but did not see any evidence of a blood clot.

Family says Ionia woman died of complications after Johnson & Johnson vaccine

The latest CDC guidance on post-vaccination life leaves a long list of questions.The latest CDC guidance on post-vaccination life leaves a long list of questions.

More than a year into the pandemic, we’re still figuring out what risks we’re willing to take - The Washington Post

Anne VanGeest, 35, died April 19 at Mercy Health Saint Mary's hospital in Grand Rapids

Woman died from complications after receiving Johnson & Johnson vaccine, family says - mlive.com

Limited vaccine supply in other countries could make global immunity tougher to achieve, though.Limited vaccine supply in other countries could make global immunity tougher to achieve, though.

U.S. Herd Immunity Could Be Coming by End of June | Morningstar

An Ionia family is mourning the death of a wife and mother after they say she died due to complications after receiving the Johnson & Johnson coronavirus vaccine.An Ionia family is mourning the death of a wife and mother after they say she died due to complications after receiving the Johnson & Johnson coronavirus vaccine.

Ionia Co. woman’s death after getting J&J vaccine reported to the CDC

German COVID-19 vaccine maker BioNTech (22UAy.DE) has continued to ramp up production allowing it to manufacture close to 3 billion doses in 2021, up from a previous target of 2.5 billion.German COVID-19 vaccine maker BioNTech (22UAy.DE) has continued to ramp up production allowing it to manufacture close to 3 billion doses in 2021, up from a previous target of 2.5 billion.

BioNTech CEO says prospective 2021 vaccine output approaching 3 bln doses | Reuters

Pfizer's (PFE) Q1 earnings and revenue exceeded analysts' expectations, while COVID-19 vaccine revenue far surpassed estimates.Pfizer's (PFE) Q1 earnings and revenue exceeded analysts' expectations, while COVID-19 vaccine revenue far surpassed estimates.

Pfizer Earnings: What Happened with PFE

With limited supply and high demand, any unused doses were rightly viewed, by both providers and the public, as wasted opportunities to immunize someone against a potentially deadly virus.With limited supply and high demand, any unused doses were rightly viewed, by both providers and the public, as wasted opportunities to immunize someone against a potentially deadly virus.

Vaccine wastage is rare in Virginia. But experts say it’s getting harder to avoid.

The site at 3230 Jackson Ave. is open 9 a.m. to 6 p.m. Monday through Friday.The site at 3230 Jackson Ave. is open 9 a.m. to 6 p.m. Monday through Friday.

Johnson & Johnson vaccination location opens Monday in Memphis

CureVac’s unique vaccine properties may be key in delivering mRNA vaccines to developing nations - Clinical Trials Arena

Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid first-quarter performance across most of the company, hiked its 2021 financial forecast after sharply after blowing past Wall ...

Pfizer's long range vaccine pursuits pay off

(Bloomberg) -- BioNTech SE, the vaccine maker partnered with Pfizer Inc. on its Covid-19 shot, rose 10% on Monday as the stock rallied past $200 a share, breaking yet another record after closing at new highs four out of five days last week.The German company was among the top gainers as the biotech sector regained lost footing and optimism about economies reopening bolstered stocks. Shots from Pfizer and BioNTech as well as Moderna Inc. have helped the U.S. reach more than 245 million doses administered, while side-stepping some of the safety concerns that have arisen for shots from AstraZeneca Plc and Johnson & Johnson.The biotech sector is bouncing back after hitting a four-month low in early April on regulatory concerns related to industry consolidation, new drug applications and potential legislation to rein in the cost of prescriptions. The Nasdaq Biotech Index is up 5.6% from an April 12 trough while the broader market climbed 1.6%. Returns for the biopharma benchmark still trail S&P 500 stocks for the year.“Vaccines are winning,” Raymond James analysts led by Chris Meekins said in a note to clients. In the U.S., infections, death and hospitalizations are still moving in the right direction, with cases now at their lowest seven-day average since early October. But other parts of the world like India are still suffering amid a massive resurgence in infections, they added.First-quarter earnings from Pfizer on Tuesday before the stock market opens could provide a further boost for the German biotech. Morgan Stanley expects the pharmaceutical heavyweight to “significantly raise” its vaccine sales expectations for the year and forecasts they could top $19 billion in 2021. Pfizer closed 3.1% higher on Monday for the biggest gain since Dec. 8 after the Biden administration said it will support its move to begin exporting U.S.-made doses of its coronavirus vaccine.Moderna also jumped 4% Monday, topping its record closing high of $185.98.Other companies waiting on critical data on their Covid-19 inoculations were mixed, including CureVac NV which rose about 2.8% while Novavax Inc. slumped 18% as investors continue to wait for its Covid vaccine data results that were expected last month.(Updates share price moves throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.(Bloomberg) -- BioNTech SE, the vaccine maker partnered with Pfizer Inc. on its Covid-19 shot, rose 10% on Monday as the stock rallied past $200 a share, breaking yet another record after closing at new highs four out of five days last week.The German company was among the top gainers as the biotech sector regained lost footing and optimism about economies reopening bolstered stocks. Shots from Pfizer and BioNTech as well as Moderna Inc. have helped the U.S. reach more than 245 million doses administered, while side-stepping some of the safety concerns that have arisen for shots from AstraZeneca Plc and Johnson & Johnson.The biotech sector is bouncing back after hitting a four-month low in early April on regulatory concerns related to industry consolidation, new drug applications and potential legislation to rein in the cost of prescriptions. The Nasdaq Biotech Index is up 5.6% from an April 12 trough while the broader market climbed 1.6%. Returns for the biopharma benchmark still trail S&P 500 stocks for the year.“Vaccines are winning,” Raymond James analysts led by Chris Meekins said in a note to clients. In the U.S., infections, death and hospitalizations are still moving in the right direction, with cases now at their lowest seven-day average since early October. But other parts of the world like India are still suffering amid a massive resurgence in infections, they added.First-quarter earnings from Pfizer on Tuesday before the stock market opens could provide a further boost for the German biotech. Morgan Stanley expects the pharmaceutical heavyweight to “significantly raise” its vaccine sales expectations for the year and forecasts they could top $19 billion in 2021. Pfizer closed 3.1% higher on Monday for the biggest gain since Dec. 8 after the Biden administration said it will support its move to begin exporting U.S.-made doses of its coronavirus vaccine.Moderna also jumped 4% Monday, topping its record closing high of $185.98.Other companies waiting on critical data on their Covid-19 inoculations were mixed, including CureVac NV which rose about 2.8% while Novavax Inc. slumped 18% as investors continue to wait for its Covid vaccine data results that were expected last month.(Updates share price moves throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

BioNTech Hits Record as Vaccine Success Spurs on Biotechs

Here are answers to questions that you may have about COVID-19 vaccine side effects.Here are answers to questions that you may have about COVID-19 vaccine side effects.

What Are COVID-19 Vaccine Side Effects, and How Long Do They Last? - COVID-19, Featured, Health Topics - Hackensack Meridian Health

The country is the first to record over 400,000 new COVID-19 cases within a 24 hour window. This crisis won't remain inside India's borders for long.The country is the first to record over 400,000 new COVID-19 cases within a 24 hour window. This crisis won't remain inside India's borders for long.

Why India's second COVID wave matters everywhere - CNET

European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old.European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old.

European regulators reviewing Pfizer vaccine for adolescents | TheHill

European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old.European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old.

European regulators reviewing Pfizer vaccine for adolescents | TheHill

“You can ship it to places that don’t have freezers. And you don’t need a qualified medical person to immunize people.”“You can ship it to places that don’t have freezers. And you don’t need a qualified medical person to immunize people.”

fortune.com

Shares of Pfizer Inc. undefined gained 2.2% in trading on Monday after the pharmaceutical company said it will donate $70 million in medicine to India, which...Shares of Pfizer Inc. undefined gained 2.2% in trading on Monday after the pharmaceutical company said it will donate $70 million in medicine to India, which...

Pfizer says it submitted application for COVID-19 vaccine to Indian regulators 'months ago' - MarketWatch

www.wsj.com

Studies analyzing vaccinated people in the real world show that COVID-19 vaccines are extremely effective, but experts are keeping an eye on variants.

Here’s what breakthrough infections reveal about COVID-19 vaccines | Science News

The Danish Health Authority said the risk of unusual blood clots as a side effect of the Johnson & Johnson vaccine outweighed its benefits.The Danish Health Authority said the risk of unusual blood clots as a side effect of the Johnson & Johnson vaccine outweighed its benefits.

Johnson & Johnson: Denmark Bans COVID Vaccine, Cites Blood Clots

The family of an Ionia-area wife and mother says she died due to complications after receiving the Johnson & Johnson COVID-19 vaccine.The family of an Ionia-area wife and mother says she died due to complications after receiving the Johnson & Johnson COVID-19 vaccine.

CDC investigating Ionia Co. woman's death after receiving Johnson & Johnson vaccine

Smaller package sizes can reduce waste and help physicians push vaccine in offices.Smaller package sizes can reduce waste and help physicians push vaccine in offices.

Pfizer to offer smaller shipments of COVID vaccine - Axios

From concerns over possible side effects to mixed messages about expiry dates, vaccine hesitancy has become a roadblock in Africa's inoculation drive...From concerns over possible side effects to mixed messages about expiry dates, vaccine hesitancy has become a roadblock in Africa's inoculation drive...

Africa's fight against COVID-19 faces vaccine hesitancy | Daily Sabah

In April, various right-wing media outlets created an online frenzy that attacked and firmly politicized “vaccine passports” — positioning the idea as a new political flashpoint in the pandemic culture war. In April, various right-wing media outlets created an online frenzy that attacked and firmly politicized “vaccine passports” — positioning the idea as a new political flashpoint in the pandemic culture war.

www.niemanlab.org

India is suffering from both a record surge in new infections and a shortage of vaccines. Pfizer has sought to quell safety fears as India continues to insist on local trials prior for foreign shots.India is suffering from both a record surge in new infections and a shortage of vaccines. Pfizer has sought to quell safety fears as India continues to insist on local trials prior for foreign shots.

India COVID crisis: Pfizer pushes for vaccine approval | News | DW | 03.05.2021

President Joe Biden is making plans for kids 12 and up to get Covid-19 vaccination shots. Here's what we know.Biden said his administration has been making plans so that this age group can begin to be vaccinated quickly.

FDA preparing to authorize Pfizer Covid vaccine for 12- to 15-year-olds as early as next week

www.bellinghamherald.com

Pfizer's COVID-19 shot did gangbusters in 2021's first quarter, but in other parts of the company's vaccine business, the pandemic took its toll. Just look at Prevnar 13, which dropped 20% in the U.S. Still, Pfizer is eyeing a co-administration study on another pneumococcal candidate that could keep Prevnar afloat amid pandemic vaccination schedules.Pfizer's COVID-19 shot did gangbusters in 2021's first quarter, but in other parts of the company's vaccine business, the pandemic took its toll. Just look at Prevnar 13, which dropped 20% in the U.S. Still, Pfizer is eyeing a co-administration study on another pneumococcal candidate that could keep Prevnar afloat amid pandemic vaccination schedules.

Prevnar 13 lags amid COVID-19 vaccine rollouts, but Pfizer sees a way to boost the franchise | FiercePharma